RPRX
Royalty Pharma Plc
57.70$
-1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | -0.8% | 88.8% | 90.2% | 91.9% | 95.9% | 88.1% | 95.8% | 126.9% | 122.3% | 104.7% | |
| – | 0.0% | 0.0% | 2.1% | 1.9% | 1.3% | 1.1% | 1.0% | 0.3% | 0.9% | 0.0% | 0.2% | |
| – | – | – | – | – | – | 0.3% | 0.1% | 0.1% | 0.1% | 0.1% | 12.2% | |
| – | 0.2% | 0.1% | -7.0% | -16.5% | -53.9% | 2.4% | 1.6% | 2.9% | – | – | – | |
| – | – | – | -92.3% | -87.0% | -92.2% | -88.8% | -0.7% | 1.5% | 0.2% | 2.4% | -0.7% | |
| – | 0.0% | 0.0% | 143.4% | 15.0% | 94.9% | 103.5% | 0.0% | 91.2% | 89.8% | 0.0% | 0.0% | |
| – | – | – | -99.4% | 16.9% | -118.7% | -130.0% | -81.7% | -46.0% | -88.0% | -118.3% | -67.9% | |
| – | – | – | 46.0% | 45.4% | 40.7% | 18.7% | 12.5% | 14.9% | 15.2% | 16.6% | 15.9% | |
| – | 0.2% | 0.2% | – | 0.0% | -0.2% | 560.3% | -20.9% | -6.4% | -12.9% | -10.1% | -51.6% | |
| – | – | – | 56.8% | -16.4% | -16.2% | 34.3% | 55.0% | -0.1% | -42.5% | 65.0% | 40.1% | |
| – | 0.0% | 0.2% | -7.7% | -76.8% | -65.7% | 70.1% | 16.8% | -42.2% | -91.3% | 16.0% | -49.9% | |
| – | -1.5% | -0.7% | -18.3% | 30.2% | -90.4% | 36.0% | 23.3% | 7.6% | -52.4% | 20.0% | -13.0% | |
| – | – | – | 88.8% | 90.2% | 91.9% | 199.4% | 88.1% | 187.1% | 126.9% | 122.3% | 104.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.